Prevalence of Frailty and Associations with Oral Anticoagulant Prescribing in Atrial Fibrillation

被引:8
|
作者
Sanghai, Saket R. [1 ]
Liu, Weisong [2 ]
Wang, Weijia [3 ]
Rongali, Subendhu [4 ]
Orkaby, Ariela R. [5 ,6 ]
Saczynski, Jane S. [7 ]
Rose, Adam J. [8 ]
Kapoor, Alok [9 ]
Li, Wenjun [9 ]
Yu, Hong [9 ,10 ]
McManus, David D. [2 ,3 ]
机构
[1] Oregon Hlth & Sci Univ, Knight Cardiovascular Inst, Div Cardiac Elect, Portland, OR 97239 USA
[2] Univ Massachusetts, Dept Populat & Quantitat Hlth Sci, Med Sch, Worcester, MA USA
[3] Univ Massachusetts, Div Cardiol, Dept Med, Med Sch, Worcester, MA USA
[4] Univ Massachusetts, Amherst, MA USA
[5] VA Boston Hlth Care Syst, New England GRECC, Boston, MA USA
[6] Harvard Med Sch, Brigham Womens Hosp, Div Aging, Boston, MA USA
[7] Northeastern Univ, Dept Pharm & Hlth Syst Sci, Boston, MA USA
[8] Boston Univ, Gen Internal Med Sect, Sch Med, Boston, MA USA
[9] Univ Massachusetts, Dept Med, Med Sch, Worcester, MA USA
[10] Edith Nourse Rogers Mem VA Med Ctr, Bedford, MA USA
关键词
atrial fibrillation; oral anticoagulation; frailty; BLEEDING RISK; STROKE; WARFARIN; TRENDS;
D O I
10.1007/s11606-021-06834-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Frailty is often cited as a factor influencing oral anticoagulation (OAC) prescription in patients with non-valvular atrial fibrillation (NVAF). We sought to determine the prevalence of frailty and its association with OAC prescription in older veterans with NVAF. METHODS: We used ICD-9 codes in Veterans Affairs (VA) records and Medicare claims data to identify patients with NVAF and CHA2DS2VASC >= 2 receiving care between February 2010 and September 2015. We examined rates of OAC prescription, further stratified by direct oral anticoagulant (DOAC) or vitamin K antagonist (VKA). Participants were characterized into 3 categories: non-frail, pre-frail, and frail based on a validated 30-item EHR-derived frailty index. We examined relations between frailty andOAC receipt; and frailty and type of OAC prescribed in regression models adjusted for factors related to OAC prescription. RESULTS: Of 308,664 veterans with NVAF and a HA2DS2VASC score >= 2, 121,839 (39%) were prescribed OAC (73% VKA). The mean age was 77.7 (9.6) years; CHA2DS2VASC and ATRIA scores were 4.6 (1.6) and 5.0 (2.9) respectively. Approximately a third (38%) were frail, another third (32%) were pre-frail, and the remainder were not frail. Veterans prescribed OAC were younger, had higher bleeding risk, and were less likely to be frail than participants not receiving OAC (all p's<0.001). After adjustment for factors associated with OAC use, pre-frail (OR: 0.89, 95% CI: 0.87-0.91) and frail (OR: 0.66, 95% CI: 0.64-0.68) veterans were significantly less likely to be prescribed OAC than non-frail veterans. Of those prescribed OAC, pre-frail (OR:1.27, 95% CI: 1.22-1.31) and frail (OR: 1.75, 95% CI: 1.67-1.83) veterans were significantly more likely than non-frail veterans to be prescribed a DOAC than a VKA. CONCLUSIONS: There are high rates of frailty among older veterans with NVAF. Frailty using an EHR-derived index is associated with decreased OAC prescription.
引用
收藏
页码:730 / 736
页数:7
相关论文
共 50 条
  • [1] Prevalence of Frailty and Associations with Oral Anticoagulant Prescribing in Atrial Fibrillation
    Saket R. Sanghai
    Weisong Liu
    Weijia Wang
    Subendhu Rongali
    Ariela R. Orkaby
    Jane S. Saczynski
    Adam J. Rose
    Alok Kapoor
    Wenjun Li
    Hong Yu
    David D. McManus
    [J]. Journal of General Internal Medicine, 2022, 37 (4) : 730 - 736
  • [2] Anticoagulant Utilization and Direct Oral Anticoagulant Prescribing in Patients with Nonvalvular Atrial Fibrillation
    Shum, Priscilla
    Klammer, Gordon
    Toews, Dale
    Barry, Arden
    [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2019, 72 (06): : 428 - 434
  • [3] Factors Influencing Oral Anticoagulant Prescribing Practices for Atrial Fibrillation
    Leung, Lester Y.
    McAllister, Mark
    Selim, Magdy
    Fisher, Marc
    [J]. JOURNAL OF STROKE, 2017, 19 (02) : 232 - 235
  • [4] Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review
    Bul, Mary
    Shaikh, Fahad
    McDonagh, Julee
    Ferguson, Caleb
    [J]. AGING MEDICINE, 2023, 6 (02) : 195 - 206
  • [5] Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
    Admassie, Endalkachew
    Chalmers, Leanne
    Bereznicki, Luke R.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (07): : 1133 - 1138
  • [6] Lower Oral Anticoagulant Prescribing for Atrial Fibrillation in Women Compared With Men
    Manja, Veena
    Phibbs, Ciaran S.
    Ananth, Lakshmi
    Saechao, Fay
    Frayne, Susan M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2024, 219 : 44 - 46
  • [7] The influence of frailty under direct oral anticoagulant use in patients with atrial fibrillation
    Yamamoto, Takashi
    Yamashita, Kentaro
    Miyamae, Kiichi
    Koyama, Yuichiro
    Izumimoto, Masataka
    Kamimura, Yoshihiro
    Hayakawa, Satoko
    Mori, Kazutaka
    Yamada, Takaaki
    Tomita, Yasushi
    Murohara, Toyoaki
    [J]. HEART ASIA, 2019, 11 (02)
  • [8] Oral Anticoagulant Prescribing in Patients with Atrial Fibrillation in a Public Continuing Care Facility
    Smyth, Louise
    Zainal, Tariq
    Crowe, Morgan
    Cogan, Lisa
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2012, 181 : S279 - S280
  • [9] Patient Factors Influencing Oral Anticoagulant Prescribing for Atrial Fibrillation After Stroke
    Sterling, Kadieann
    Langhorne, Peter
    Macleod, Mary J.
    Turner, Melanie
    [J]. STROKE, 2020, 51
  • [10] Oral anticoagulant prescribing in elderly patients above and below age 80 with atrial fibrillation
    Xie, Kun
    Shen, Jun
    Xiong, Nanqing
    Li, Jian
    Ni, Huanchun
    Yuan, Fei
    Zhang, Jinjin
    Chen, Hua
    Gao, Wen
    Jiang, Xiaofei
    Luo, Xinping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 57 (09) : 458 - 463